𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

✍ Scribed by Jairo A. Garcia; Lewis R. Roberts


Book ID
116652588
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
182 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES